Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Thrombocytopenia 2Primary Myelofibrosis 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid, Accelerated Phase 1Blast Crisis 1

Interventions

Cyclophosphamide 3fludarabine phosphate 2Radiotherapy 2Methylprednisolone 2Filgrastim 2Antilymphocyte Serum 2eltrombopag 1Whole-Body Irradiation 1Thiotepa 1Tacrolimus 1Methotrexate 1Melphalan 1Etoposide 1Cytarabine 1Cyclosporine 1Carboplatin 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Leukemia, Myeloid, Accelerated Phase × eltrombopag × Clear all
NCT01428635 2023-09-26

Eltrombopag Olamine in Treating Thrombocytopenia in Patients With Chronic Myeloid Leukemia or Myelofibrosis Receiving Tyrosine Kinase Therapy

M.D. Anderson Cancer Center

Phase 2/3 Completed
21 enrolled 10 charts
Classical hematologyMyeloidOther hematologic neoplasm

Blast Crisis, Thrombocytopenia, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡